Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 9Other hematologic neoplasm 9Lymphoid 7Myeloid 5Classical hematology 2Sarcoma 1Genitourinary 1

Conditions

Carcinoma, Renal Cell 22Kidney Neoplasms 19Melanoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia, Myeloid, Acute 6Recurrence 5Neoplasm Metastasis 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Waldenstrom Macroglobulinemia 4Uterine Cervical Neoplasms 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Lymphoma 4Leukemia 4Dendritic Cell Sarcoma, Interdigitating 4Burkitt Lymphoma 4Breast Neoplasms 4

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Cyclosporins 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Plasma Cell × fludarabine phosphate × Genitourinary × Clear all
NCT00027820 2019-12-20

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
106 enrolled
Classical hematologyGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡